Works matching IS 00139580 AND DT 2022 AND VI 63
Results: 321
Epilepsia – December 2022 – Announcements.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3216, doi. 10.1111/epi.17458
- Publication type:
- Article
Corrigendum to "Brain network excitatory/inhibitory imbalance is a biomarker for drug‐naive Rolandic epilepsy: A radiomics strategy". [Epilepsia 2021, 62 (10): 2426–2438].
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3215, doi. 10.1111/epi.17443
- Publication type:
- Article
The nuances of immunotherapy for NORSE/FIRES.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3212, doi. 10.1111/epi.17439
- By:
- Publication type:
- Article
Seizures in anti‐Hu–associated extra‐limbic encephalitis: Characterization of a unique disease manifestation.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. e172, doi. 10.1111/epi.17437
- By:
- Publication type:
- Article
Association between the risk of seizure and COVID‐19 vaccinations: A self‐controlled case‐series study.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3100, doi. 10.1111/epi.17436
- By:
- Publication type:
- Article
Progressive slowing of clonic phase predicts postictal generalized EEG suppression.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3204, doi. 10.1111/epi.17434
- By:
- Publication type:
- Article
Altered cerebellar‐motor loop in benign adult familial myoclonic epilepsy type 1: The structural basis of cortical tremor.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3192, doi. 10.1111/epi.17430
- By:
- Publication type:
- Article
A systems medicine strategy to predict the efficacy of drugs for monogenic epilepsies.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3125, doi. 10.1111/epi.17429
- By:
- Publication type:
- Article
Neurobehavioral deficits and a progressive ictogenesis in the tetrodotoxin model of epileptic spasms.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3078, doi. 10.1111/epi.17428
- By:
- Publication type:
- Article
Successful treatment of adult Dravet syndrome patients with cenobamate.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. e164, doi. 10.1111/epi.17427
- By:
- Publication type:
- Article
Seizure outcome determinants in children after surgery for single unilateral lesions on magnetic resonance imaging: Role of preoperative ictal and interictal electroencephalography.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3168, doi. 10.1111/epi.17425
- By:
- Publication type:
- Article
Acute symptomatic seizures secondary to myelin oligodendrocyte glycoprotein antibody‐associated disease.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3180, doi. 10.1111/epi.17424
- By:
- Publication type:
- Article
Lacosamide decreases neonatal seizures without increasing apoptosis.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3051, doi. 10.1111/epi.17423
- By:
- Publication type:
- Article
Paroxysmal fast activity is a biomarker of treatment response in deep brain stimulation for Lennox–Gastaut syndrome.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3134, doi. 10.1111/epi.17414
- By:
- Publication type:
- Article
Bone development in offspring of pregnant rats treated with carbamazepine: Evaluation by three different methods.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3066, doi. 10.1111/epi.17422
- By:
- Publication type:
- Article
Synergistic effects of the galanin analog 810–2 with the antiseizure medication levetiracetam in rodent seizure models.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3090, doi. 10.1111/epi.17420
- By:
- Publication type:
- Article
A gain‐of‐function GRIA2 variant associated with neurodevelopmental delay and seizures: Functional characterization and targeted treatment.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. e156, doi. 10.1111/epi.17419
- By:
- Publication type:
- Article
Gene panel to guide antiseizure medication prescribing: Does the cost justify the benefits?
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3122, doi. 10.1111/epi.17418
- By:
- Publication type:
- Article
Seizure count forecasting to aid diagnostic testing in epilepsy.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3156, doi. 10.1111/epi.17415
- By:
- Publication type:
- Article
Deficit in observational learning in experimental epilepsy.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. e150, doi. 10.1111/epi.17421
- By:
- Publication type:
- Article
Drug‐resistant epilepsy and mortality—Why and when do neuromodulation and epilepsy surgery reduce overall mortality.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3020, doi. 10.1111/epi.17413
- By:
- Publication type:
- Article
Drug resistance in idiopathic generalized epilepsies: Evidence and concepts.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3007, doi. 10.1111/epi.17410
- By:
- Publication type:
- Article
Early cost–utility analysis of genetically guided therapy for patients with drug‐resistant epilepsy.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3111, doi. 10.1111/epi.17408
- By:
- Publication type:
- Article
The longitudinal effect of oxcarbazepine on thyroid function in children and adolescents with epilepsy.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3148, doi. 10.1111/epi.17407
- By:
- Publication type:
- Article
Functional neuropathology of neonatal hypoxia‐ischemia by single‐mouse longitudinal electroencephalography.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. 3037, doi. 10.1111/epi.17403
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 12, p. i, doi. 10.1111/epi.16568
- Publication type:
- Article
Epilepsia – November 2022 – Announcements.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 3005, doi. 10.1111/epi.17435
- Publication type:
- Article
Time to exceed pre‐randomization monthly seizure count for perampanel in participants with primary generalized tonic–clonic seizures: A potential clinical end point.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2994, doi. 10.1111/epi.17411
- By:
- Publication type:
- Article
Identification of patients with drug‐resistant epilepsy in electronic medical record data using the Observational Medical Outcomes Partnership Common Data Model.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2981, doi. 10.1111/epi.17409
- By:
- Publication type:
- Article
Mouse models of Kcnq2 dysfunction.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2813, doi. 10.1111/epi.17405
- By:
- Publication type:
- Article
Association of ictal imaging changes in status epilepticus and neurological deterioration.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2970, doi. 10.1111/epi.17404
- By:
- Publication type:
- Article
Lacosamide effects on placental carriers of essential compounds in comparison with valproate: Studies in perfused human placentas.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2949, doi. 10.1111/epi.17395
- By:
- Publication type:
- Article
Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2937, doi. 10.1111/epi.17402
- By:
- Publication type:
- Article
Effects of CYP2C19 genetic polymorphisms on the pharmacokinetics of lacosamide in Korean patients with epilepsy.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2958, doi. 10.1111/epi.17399
- By:
- Publication type:
- Article
Incidence and risk factors of posttraumatic epilepsy following pediatric traumatic brain injury: A systematic review and meta‐analysis.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2802, doi. 10.1111/epi.17398
- By:
- Publication type:
- Article
International consensus recommendations for management of new onset refractory status epilepticus including febrile infection‐related epilepsy syndrome: Statements and supporting evidence.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2840, doi. 10.1111/epi.17397
- By:
- Publication type:
- Article
GluN2C selective inhibition is a target to develop new antiepileptic compounds.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2911, doi. 10.1111/epi.17396
- By:
- Publication type:
- Article
Serotonin receptor expression in hippocampus and temporal cortex of temporal lobe epilepsy patients by postictal generalized electroencephalographic suppression duration.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2925, doi. 10.1111/epi.17400
- By:
- Publication type:
- Article
International consensus recommendations for management of new onset refractory status epilepticus (NORSE) including febrile infection‐related epilepsy syndrome (FIRES): Summary and clinical tools.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2827, doi. 10.1111/epi.17391
- By:
- Publication type:
- Article
Decision‐making in stereotactic epilepsy surgery.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2782, doi. 10.1111/epi.17381
- By:
- Publication type:
- Article
Progress report on new antiepileptic drugs: A summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI): II. Drugs in more advanced clinical development.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2883, doi. 10.1111/epi.17376
- By:
- Publication type:
- Article
Progress report on new antiepileptic drugs: A summary of the Sixteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVI): I. Drugs in preclinical and early clinical development.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2865, doi. 10.1111/epi.17373
- By:
- Publication type:
- Article
Quantifying and reporting outcome measures in pediatric epilepsy surgery: A systematic review.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2754, doi. 10.1111/epi.17369
- By:
- Publication type:
- Article
Wearable OPM‐MEG: A changing landscape for epilepsy.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2745, doi. 10.1111/epi.17368
- By:
- Publication type:
- Article
Electroencephalography–functional magnetic resonance imaging of epileptiform discharges: Noninvasive investigation of the whole brain.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. 2725, doi. 10.1111/epi.17364
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 11, p. i, doi. 10.1111/epi.16567
- Publication type:
- Article
Epilepsia—October 2022—Announcements.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 10, p. 2722, doi. 10.1111/epi.17417
- Publication type:
- Article
Compound‐heterozygous GRIN2A null variants associated with severe developmental and epileptic encephalopathy.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 10, p. e132, doi. 10.1111/epi.17394
- By:
- Publication type:
- Article
Seizures following COVID‐19 vaccination in Mexico: A nationwide observational study.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 10, p. e144, doi. 10.1111/epi.17390
- By:
- Publication type:
- Article
Why are type II focal cortical dysplasias frequently located at the bottom of sulcus? A neurodevelopmental hypothesis.
- Published in:
- Epilepsia (Series 4), 2022, v. 63, n. 10, p. 2716, doi. 10.1111/epi.17386
- By:
- Publication type:
- Article